Drug Profile
Moraxella catarrhalis vaccine - Wyeth
Latest Information Update: 03 Oct 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Moraxella infections
Most Recent Events
- 22 Jun 2001 No-Development-Reported for Moraxella infections in USA (Unknown route)
- 17 Jul 1997 New profile
- 17 Jul 1997 Preclinical development for Moraxella infections in USA (Unknown route)